The role of immunotherapy in fusion-driven lung cancer.
Publication
, Journal Article
Tan, AC; Chan, J; Khasraw, M
Published in: Expert Rev Anticancer Ther
May 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Expert Rev Anticancer Ther
DOI
EISSN
1744-8328
Publication Date
May 2021
Volume
21
Issue
5
Start / End Page
461 / 464
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Gene Fusion
- Carcinoma, Non-Small-Cell Lung
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Tan, A. C., Chan, J., & Khasraw, M. (2021). The role of immunotherapy in fusion-driven lung cancer. Expert Rev Anticancer Ther, 21(5), 461–464. https://doi.org/10.1080/14737140.2021.1899816
Tan, Aaron C., Johan Chan, and Mustafa Khasraw. “The role of immunotherapy in fusion-driven lung cancer.” Expert Rev Anticancer Ther 21, no. 5 (May 2021): 461–64. https://doi.org/10.1080/14737140.2021.1899816.
Tan AC, Chan J, Khasraw M. The role of immunotherapy in fusion-driven lung cancer. Expert Rev Anticancer Ther. 2021 May;21(5):461–4.
Tan, Aaron C., et al. “The role of immunotherapy in fusion-driven lung cancer.” Expert Rev Anticancer Ther, vol. 21, no. 5, May 2021, pp. 461–64. Pubmed, doi:10.1080/14737140.2021.1899816.
Tan AC, Chan J, Khasraw M. The role of immunotherapy in fusion-driven lung cancer. Expert Rev Anticancer Ther. 2021 May;21(5):461–464.
Published In
Expert Rev Anticancer Ther
DOI
EISSN
1744-8328
Publication Date
May 2021
Volume
21
Issue
5
Start / End Page
461 / 464
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Lung Neoplasms
- Immunotherapy
- Humans
- Gene Fusion
- Carcinoma, Non-Small-Cell Lung
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis